chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Right shoulder swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Right shoulder swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rotator cuff repair in 2013. Concomitant products included FENOFIBRIC ACID and ATORVASTATIN for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced SWELLING (Right shoulder swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-Jan-2021, SWELLING (Right shoulder swollen) had resolved.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, SARS-CoV-2 test: positive (Inconclusive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided Treatment information provided as Monoclonal antibody treatments
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Illness, Impaired work ability, Myalgia, Peripheral swelling
Clinical narrative: sick in bed; Couldn't go to work; red and swollen arm and a sore muscle on the left side of her back; red and swollen arm and a sore muscle on the left side of her back; red and swollen arm and a sore muscle on the left side of her back; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick in bed), IMPAIRED WORK ABILITY (Couldn't go to work), ERYTHEMA (red and swollen arm and a sore muscle on the left side of her back), PERIPHERAL SWELLING (red and swollen arm and a sore muscle on the left side of her back) and MYALGIA (red and swollen arm and a sore muscle on the left side of her back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick in bed), IMPAIRED WORK ABILITY (Couldn't go to work), ERYTHEMA (red and swollen arm and a sore muscle on the left side of her back), PERIPHERAL SWELLING (red and swollen arm and a sore muscle on the left side of her back) and MYALGIA (red and swollen arm and a sore muscle on the left side of her back). At the time of the report, ILLNESS (sick in bed), IMPAIRED WORK ABILITY (Couldn't go to work), ERYTHEMA (red and swollen arm and a sore muscle on the left side of her back), PERIPHERAL SWELLING (red and swollen arm and a sore muscle on the left side of her back) and MYALGIA (red and swollen arm and a sore muscle on the left side of her back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Action taken with mRNA-1273 in response to the events was not applicable. No treatment information was reported. No concomitant medications reported by investigator    This case was linked to MOD-2021-024446, MOD21-023209,MOD21-023250 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Significant Follow up received on 29-JUN-2021:Events added
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Red tiny dimple; Huge oval shape hard (real hard and bony) bump; Burring when touched; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red tiny dimple), VACCINATION SITE SWELLING (Huge oval shape hard (real hard and bony) bump) and VACCINATION SITE PAIN (Burring when touched) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Shingles.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red tiny dimple), VACCINATION SITE SWELLING (Huge oval shape hard (real hard and bony) bump) and VACCINATION SITE PAIN (Burring when touched). At the time of the report, VACCINATION SITE ERYTHEMA (Red tiny dimple) and VACCINATION SITE PAIN (Burring when touched) outcome was unknown and VACCINATION SITE SWELLING (Huge oval shape hard (real hard and bony) bump) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included no  only used (baking soda mixed with water).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Pruritus, Pyrexia, Rash
Clinical narrative: burning like fire behind knee; it itched behind knee; it was dark cranberry red; rash started to spread in dots to other parts of her body; a rash behind her right knee; ran a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee), ERYTHEMA (it was dark cranberry red), URTICARIA (rash started to spread in dots to other parts of her body) and RASH (a rash behind her right knee) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee), ERYTHEMA (it was dark cranberry red), URTICARIA (rash started to spread in dots to other parts of her body), RASH (a rash behind her right knee) and PYREXIA (ran a low grade fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ALOE VERA at an unspecified dose and frequency. On 15-Feb-2021, PYREXIA (ran a low grade fever) had resolved. At the time of the report, BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee) and ERYTHEMA (it was dark cranberry red) outcome was unknown and URTICARIA (rash started to spread in dots to other parts of her body) and RASH (a rash behind her right knee) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include stomach medications.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Telephone contact report was received on 14-JUL-2021 and contains significant information and start date of fever was updated and outcome of rash was updated to not recovered/ongoing and concomitant medications which were missed initially it was captured now and  reporter contact details were updated.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: burning like fire behind knee; it itched behind knee; it was dark cranberry red; rash started to spread in dots to other parts of her body; a rash behind her right knee; ran a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee), ERYTHEMA (it was dark cranberry red), URTICARIA (rash started to spread in dots to other parts of her body) and RASH (a rash behind her right knee) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee), ERYTHEMA (it was dark cranberry red), URTICARIA (rash started to spread in dots to other parts of her body), RASH (a rash behind her right knee) and PYREXIA (ran a low grade fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ALOE VERA at an unspecified dose and frequency. On 15-Feb-2021, PYREXIA (ran a low grade fever) had resolved. At the time of the report, BURNING SENSATION (burning like fire behind knee), PRURITUS (it itched behind knee) and ERYTHEMA (it was dark cranberry red) outcome was unknown and URTICARIA (rash started to spread in dots to other parts of her body) and RASH (a rash behind her right knee) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include stomach medications.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Telephone contact report was received on 14-JUL-2021 and contains significant information and start date of fever was updated and outcome of rash was updated to not recovered/ongoing and concomitant medications which were missed initially it was captured now and  reporter contact details were updated.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Splitting headaches; General body aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HEADACHE (Splitting headaches) and MYALGIA (General body aches) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history.).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (Splitting headaches). In February 2021, the patient experienced MYALGIA (General body aches). At the time of the report, HEADACHE (Splitting headaches) and MYALGIA (General body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment details were not provided.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: was extremely sore to the touch; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (was extremely sore to the touch) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (was extremely sore to the touch) and HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, PAIN (was extremely sore to the touch) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Fatigue, Pain in extremity
Clinical narrative: Blood sugar uncontrolled; Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, BLOOD GLUCOSE ABNORMAL (Blood sugar uncontrolled) had resolved and PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Vaccination site pain
Clinical narrative: shortness of breath; chills; pain like someone punched him at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), CHILLS (chills) and VACCINATION SITE PAIN (pain like someone punched him at the injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), CHILLS (chills) and VACCINATION SITE PAIN (pain like someone punched him at the injection site). At the time of the report, DYSPNOEA (shortness of breath), CHILLS (chills) and VACCINATION SITE PAIN (pain like someone punched him at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Heart rate increased, Hypertension, Oxygen saturation
Clinical narrative: Dizzy; rapid pulse; blood pressure went to roof; Extremely white; Weak; A spontaneous report was received from a consumer (patient) concerning 72 years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).  The patient's medical history was not reported. The concomitant medications included warfarin sodium for twenty years and blood thinner pills.  On 04 Feb 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot: 039K20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 04 Feb 2021, the patient reported that after the shot she felt very dizzy, weak, had very rapid pulse, blood pressure went to roof, did not have any other severe allergic reaction, her oxygen level was okay. The nurse told her she was extremely white and they put the mask away. On the same day, after 15 minutes her oxygen was still good, blood pressure started getting better, no swelling. On the same day, after 15 minutes more she was getting better, had no problems in her throat and no trouble breathing. After the 30 minutes nurse asked her to stay 15 minutes more, she waited and everything was fine, she had no other reaction or other side effects.  Treatment received for the event was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  On 04 Feb 2021, the events of dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia) were resolved.  The reporter did not provide assessment for the events dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor
Clinical narrative: Dizzy; rapid pulse; blood pressure went to roof; Extremely white; Weak; A spontaneous report was received from a consumer (patient) concerning 72 years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).  The patient's medical history was not reported. The concomitant medications included warfarin sodium for twenty years and blood thinner pills.  On 04 Feb 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot: 039K20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 04 Feb 2021, the patient reported that after the shot she felt very dizzy, weak, had very rapid pulse, blood pressure went to roof, did not have any other severe allergic reaction, her oxygen level was okay. The nurse told her she was extremely white and they put the mask away. On the same day, after 15 minutes her oxygen was still good, blood pressure started getting better, no swelling. On the same day, after 15 minutes more she was getting better, had no problems in her throat and no trouble breathing. After the 30 minutes nurse asked her to stay 15 minutes more, she waited and everything was fine, she had no other reaction or other side effects.  Treatment received for the event was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  On 04 Feb 2021, the events of dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia) were resolved.  The reporter did not provide assessment for the events dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site reaction, Vaccination site warmth
Clinical narrative: the redness came down to her elbow and it was a couple of inches wide; a week after the arm of the injection site was warm; week after the arm of the injection site was round; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (a week after the arm of the injection site was warm), VACCINATION SITE REACTION (week after the arm of the injection site was round) and INJECTION SITE ERYTHEMA (the redness came down to her elbow and it was a couple of inches wide) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (a week after the arm of the injection site was warm) and VACCINATION SITE REACTION (week after the arm of the injection site was round). On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (the redness came down to her elbow and it was a couple of inches wide). At the time of the report, VACCINATION SITE WARMTH (a week after the arm of the injection site was warm), VACCINATION SITE REACTION (week after the arm of the injection site was round) and INJECTION SITE ERYTHEMA (the redness came down to her elbow and it was a couple of inches wide) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Already had rash due to immunotherapy/ significantly worse due to vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (Already had rash due to immunotherapy/ significantly worse due to vaccine) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chemotherapy and Rash (already had rash due to immunotherapy).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Already had rash due to immunotherapy/ significantly worse due to vaccine). The patient was treated with Immunotherapy (Already had rash due to Immunotherapy) for Rash. At the time of the report, RASH (Already had rash due to immunotherapy/ significantly worse due to vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included were immunotherapy and chemotherapy. Treatment medication were corticosteroids.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Contusion, Dysmorphism, Eye pain, Fatigue
Clinical narrative: had an inflammatory reaction; Sharp pain in stomach; Pain in foot, Pain gets worse specially at night; Drawing down the right side of the face; tiredness; Sleep excessive; Pain in eye; bruising; neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), CONTUSION (bruising) and INFLAMMATION (had an inflammatory reaction) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu (At the age of 15 the patient took the Compazine to treat the flu. recalled experiences of muscle twitches in her face which are very painful and affected her tongue and eye), Migraine (Headaches and nausea from migraine) and Knee replacement (Full knee replacement) in 2014. Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, ATORVASTATIN and BUTALBITAL;CAFFEINE;CODEINE PHOSPHATE;PARACETAMOL for an unknown indication, PROMETHAZINE.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NECK PAIN (neck pain) and CONTUSION (bruising). On an unknown date, the patient experienced HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), INFLAMMATION (had an inflammatory reaction), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness). The patient was treated with LOSARTAN at a dose of 50 mg. At the time of the report, NECK PAIN (neck pain) and EYE PAIN (Pain in eye) had resolved, HYPERSOMNIA (Sleep excessive), CONTUSION (bruising), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness) outcome was unknown and INFLAMMATION (had an inflammatory reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Inflammation, Neck pain, Pain in extremity
Clinical narrative: had an inflammatory reaction; Sharp pain in stomach; Pain in foot, Pain gets worse specially at night; Drawing down the right side of the face; tiredness; Sleep excessive; Pain in eye; bruising; neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), CONTUSION (bruising) and INFLAMMATION (had an inflammatory reaction) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu (At the age of 15 the patient took the Compazine to treat the flu. recalled experiences of muscle twitches in her face which are very painful and affected her tongue and eye), Migraine (Headaches and nausea from migraine) and Knee replacement (Full knee replacement) in 2014. Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, ATORVASTATIN and BUTALBITAL;CAFFEINE;CODEINE PHOSPHATE;PARACETAMOL for an unknown indication, PROMETHAZINE.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NECK PAIN (neck pain) and CONTUSION (bruising). On an unknown date, the patient experienced HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), INFLAMMATION (had an inflammatory reaction), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness). The patient was treated with LOSARTAN at a dose of 50 mg. At the time of the report, NECK PAIN (neck pain) and EYE PAIN (Pain in eye) had resolved, HYPERSOMNIA (Sleep excessive), CONTUSION (bruising), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness) outcome was unknown and INFLAMMATION (had an inflammatory reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Nausea, Pyrexia
Clinical narrative: low grade fever; nausea; diarrhea; stomach pain; This spontaneous case was reported by an other health professional (subsequently medically confirmed) and describes the occurrence of PYREXIA (low grade fever), NAUSEA (nausea), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder on 17-Feb-2021.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 17-Feb-2021, the patient experienced PYREXIA (low grade fever), NAUSEA (nausea), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach pain). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) on 17-Feb-2021 for Diarrhea, at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) on 17-Feb-2021 for Nausea, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (low grade fever), NAUSEA (nausea), DIARRHOEA (diarrhea) and ABDOMINAL PAIN UPPER (stomach pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Swollen tongue, Vaccination site erythema, Vaccination site mass, Vaccination site swelling
Clinical narrative: Her tongue was swollen; Arm at the injection site is lumpy; Lump in her right arm; Arm at the injection site is red; Left arm at the injection site is swollen at about 5-6inches long; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Her tongue was swollen), VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (The patient was allergic to oxycodone.). Concomitant products included ACYCLOVIR [ACICLOVIR] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced SWOLLEN TONGUE (Her tongue was swollen), VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 07-Feb-2021, SWOLLEN TONGUE (Her tongue was swollen) had resolved. At the time of the report, VACCINATION SITE MASS (Arm at the injection site is lumpy), MASS (Lump in her right arm), VACCINATION SITE ERYTHEMA (Arm at the injection site is red) and VACCINATION SITE SWELLING (Left arm at the injection site is swollen at about 5-6inches long) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Diarrhoea, Heart rate, Heart rate irregular
Clinical narrative: Tachycardia at 65 and then shoot up to 120 and 125; Erratic heartbeat; She could not move; Bone pain; Diarrhea; Fever/Had at 103, 104.8; Nausea; Vomiting; Muscle pain; Lymph nodes swollen up underneath arm and neck; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain) and DIARRHOEA (Diarrhea) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 07M20A and 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis since an unknown date and Antiphospholipid syndrome (Patient had markers APS and rheumatoid arthritis but did not take medication) since an unknown date.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck). At the time of the report, TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 103 f (High) AT 2am  had at 103, 104.8 for 5 hours straight.. On 04-Feb-2021, Heart rate: 65 Patient experience tachycardia at 65 and then shoot up to 120 and 125..         No relevant concomitant medications were reported. Treatment medications included Tylenol and Advil.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Movement disorder, Myalgia, Nausea, Pyrexia
Clinical narrative: Tachycardia at 65 and then shoot up to 120 and 125; Erratic heartbeat; She could not move; Bone pain; Diarrhea; Fever/Had at 103, 104.8; Nausea; Vomiting; Muscle pain; Lymph nodes swollen up underneath arm and neck; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain) and DIARRHOEA (Diarrhea) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 07M20A and 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis since an unknown date and Antiphospholipid syndrome (Patient had markers APS and rheumatoid arthritis but did not take medication) since an unknown date.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck). At the time of the report, TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 103 f (High) AT 2am  had at 103, 104.8 for 5 hours straight.. On 04-Feb-2021, Heart rate: 65 Patient experience tachycardia at 65 and then shoot up to 120 and 125..         No relevant concomitant medications were reported. Treatment medications included Tylenol and Advil.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vomiting
Clinical narrative: Tachycardia at 65 and then shoot up to 120 and 125; Erratic heartbeat; She could not move; Bone pain; Diarrhea; Fever/Had at 103, 104.8; Nausea; Vomiting; Muscle pain; Lymph nodes swollen up underneath arm and neck; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain) and DIARRHOEA (Diarrhea) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 07M20A and 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis since an unknown date and Antiphospholipid syndrome (Patient had markers APS and rheumatoid arthritis but did not take medication) since an unknown date.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck). At the time of the report, TACHYCARDIA (Tachycardia at 65 and then shoot up to 120 and 125), HEART RATE IRREGULAR (Erratic heartbeat), MOVEMENT DISORDER (She could not move), BONE PAIN (Bone pain), DIARRHOEA (Diarrhea), PYREXIA (Fever/Had at 103, 104.8), NAUSEA (Nausea), VOMITING (Vomiting), MYALGIA (Muscle pain) and LYMPHADENOPATHY (Lymph nodes swollen up underneath arm and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: 103 f (High) AT 2am  had at 103, 104.8 for 5 hours straight.. On 04-Feb-2021, Heart rate: 65 Patient experience tachycardia at 65 and then shoot up to 120 and 125..         No relevant concomitant medications were reported. Treatment medications included Tylenol and Advil.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: headaches; body aches; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HEADACHE (headaches) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030LZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) and MYALGIA (body aches). At the time of the report, HEADACHE (headaches) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Muscular weakness, Pain in extremity
Clinical narrative: dizziness; weak legs; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN IN EXTREMITY (sore arm) and MUSCULAR WEAKNESS (weak legs) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Feb-2021, the patient experienced DIZZINESS (dizziness) and MUSCULAR WEAKNESS (weak legs). On 06-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, DIZZINESS (dizziness) and MUSCULAR WEAKNESS (weak legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: NNI
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Pain in the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in the shoulder) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiovascular disease, unspecified. Concomitant products included APIXABAN (ELIQUIS), LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, METOPROLOL SUCCINATE (TOPROL), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced ARTHRALGIA (Pain in the shoulder). At the time of the report, ARTHRALGIA (Pain in the shoulder) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was planning to take Extra strength Tylenol as treatment.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Therapeutic response unexpected, Vaccination site swelling
Clinical narrative: Arm hurt a little; Itchy area under her ear on the right side of her neck; lymph nodes in my neck were not swollen any more; Swelling around the shot area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt a little), PRURITUS (Itchy area under her ear on the right side of her neck), THERAPEUTIC RESPONSE UNEXPECTED (lymph nodes in my neck were not swollen any more) and VACCINATION SITE SWELLING (Swelling around the shot area) in a 71-year-old female patient who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt a little), PRURITUS (Itchy area under her ear on the right side of her neck), THERAPEUTIC RESPONSE UNEXPECTED (lymph nodes in my neck were not swollen any more) and VACCINATION SITE SWELLING (Swelling around the shot area). On 07-Feb-2021, PAIN IN EXTREMITY (Arm hurt a little) had resolved. On 08-Feb-2021, PRURITUS (Itchy area under her ear on the right side of her neck), THERAPEUTIC RESPONSE UNEXPECTED (lymph nodes in my neck were not swollen any more) and VACCINATION SITE SWELLING (Swelling around the shot area) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.       no concomitant medications are provided by the reporter.   This case was linked to MOD-2021-086945 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: follow up information received on 21-apr-2021, added information as Your interpretation of my original feedback is incorrect .when she received 1st dose of vaccine lymph nodes in my neck were not swollen any more. she did have swelling around the shot area and I felt stinky but nothing else.after second dose of vaccine swelling around my hips and knees went way down. but the reduction in swelling of my joints was wonderful relief.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: Loss of appetite; Short of breath; Little tired; Shivering; Body aches; Balance problems; Didn't feel good; Feeling of fogginess; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), DECREASED APPETITE (Loss of appetite), BALANCE DISORDER (Balance problems) and DYSPNOEA (Short of breath) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 22-Aug-2020. Concurrent medical conditions included High cholesterol. Concomitant products included SIMVASTATIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), BALANCE DISORDER (Balance problems), CHILLS (Shivering) and PAIN (Body aches). On 06-Feb-2021, the patient experienced FATIGUE (Little tired). On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite) and DYSPNOEA (Short of breath). At the time of the report, MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), DECREASED APPETITE (Loss of appetite), BALANCE DISORDER (Balance problems), CHILLS (Shivering) and PAIN (Body aches) was resolving and DYSPNOEA (Short of breath) and FATIGUE (Little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No treatment information was reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Pain
Clinical narrative: Loss of appetite; Short of breath; Little tired; Shivering; Body aches; Balance problems; Didn't feel good; Feeling of fogginess; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), DECREASED APPETITE (Loss of appetite), BALANCE DISORDER (Balance problems) and DYSPNOEA (Short of breath) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 22-Aug-2020. Concurrent medical conditions included High cholesterol. Concomitant products included SIMVASTATIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), BALANCE DISORDER (Balance problems), CHILLS (Shivering) and PAIN (Body aches). On 06-Feb-2021, the patient experienced FATIGUE (Little tired). On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite) and DYSPNOEA (Short of breath). At the time of the report, MALAISE (Didn't feel good), FEELING ABNORMAL (Feeling of fogginess), DECREASED APPETITE (Loss of appetite), BALANCE DISORDER (Balance problems), CHILLS (Shivering) and PAIN (Body aches) was resolving and DYSPNOEA (Short of breath) and FATIGUE (Little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No treatment information was reported.